Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for patients with COVID-19—Nashville, Tennessee

WB Stubblefield, HK Talbot, LR Feldstein… - Clinical infectious …, 2021 - academic.oup.com
Among 249 healthcare personnel who worked in hospital units with COVID-19 patients for 1
month, 19 (7.6%) tested positive for SARS-CoV-2 antibodies. Only 11 (57.9%) of the 19 …

Community transmission of severe acute respiratory syndrome coronavirus 2 disproportionately affects the Latinx population during shelter-in-place in San Francisco

G Chamie, C Marquez, E Crawford… - Clinical Infectious …, 2021 - academic.oup.com
Background There is an urgent need to understand the dynamics and risk factors driving
ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission …

[PDF][PDF] Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

KL Bajema, RE Wiegand, K Cuffe, SV Patel… - JAMA internal …, 2021 - jamanetwork.com
Importance Case-based surveillance of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection likely underestimates the true prevalence of infections. Large-scale …

Trends over time in the risk of adverse outcomes among patients with severe acute respiratory syndrome coronavirus 2 infection

GN Ioannou, AM O'Hare, K Berry, VS Fan… - Clinical Infectious …, 2022 - academic.oup.com
Background We aimed to describe trends in adverse outcomes among patients who tested
positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between …

Reinfection with severe acute respiratory syndrome coronavirus 2 among previously infected healthcare personnel and first responders

LJ Akinbami, BJ Biggerstaff, PA Chan… - Clinical Infectious …, 2022 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus testing
among first responders and healthcare personnel who participated in a May 2020–August …

COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State—March 2020

ES Rosenberg, EM Dufort, DS Blog… - Clinical Infectious …, 2020 - academic.oup.com
Background The US'coronavirus disease 2019 (COVID-19) epidemic has grown extensively
since February 2020, with substantial associated hospitalizations and mortality; New York …

Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020

KN Althoff, DJ Schlueter, H Anton-Culver… - Clinical Infectious …, 2022 - academic.oup.com
Background With limited severe acute respiratory syndrome coronavirus (SARS-CoV-2)
testing capacity in the United States at the start of the epidemic (January–March 2020) …

[HTML][HTML] Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network—12 states, April–August 2020

WH Self - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Among 156 frontline health care personnel who had positive SARS-CoV-2 antibody test
results in spring 2020, 94% experienced a decline at repeat testing approximately 60 days …

Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore

BE Young, SWX Ong, S Kalimuddin, JG Low, SY Tan… - Jama, 2020 - jamanetwork.com
Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China, in December 2019 and has spread globally with sustained human-to-human …

Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the …

RE Wiegand, Y Deng, X Deng, A Lee… - The Lancet Regional …, 2023 - thelancet.com
Background Sero-surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) can reveal trends and differences in subgroups and capture undetected or …